Pharmafile Logo
Pharmafocus logo
Advanced Search
celltherapy

Cell Therapy signs £12.5 million licensing deal with Daiichi Sankyo for heart failure treatment

May 10, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Daiichi Sankyo, Deals, cell therapy, heart failure, licensing

UK-based Cell Therapy on Tuesday said it has signed a £12.5 million licensing deal with Japan’s Daiichi Sankyo (TYO: 4568) …

News
medivation

Medivation maybe mulling sale as bidding race heats up – Reports

May 10, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Deals, M&A, MA, Medivation, Pfizer, Sanofi

Cancer drugmaker Medivation (Nasdaq: MDVN) is evaluating a potential sale following the recent string of offers from big pharma firms, …

News
vaccination

Takeda secures $38 million grant to develop affordable polio vaccine

May 10, 2016
Manufacturing and Production, Research and Development Bill and Melinda Gates Foundation, Gates Foundation, Takeda, Vaccine, access, developing countries, grant, polio

Takeda Pharmaceuticals has received a $38 million grant from the Bill and Melinda Gates Foundation to develop a low-cost polio …

News

Scottish Medicines Consortium does not back Vertex’ cystic fibrosis drugs Orkambi, Kalydeco

May 10, 2016
Manufacturing and Production, Research and Development Kalydeco, Orkambi, SMC, Vertex Pharma, cystic fibrosis, regulation

The Scottish Medicines Consortium did not back two cystic fibrosis therapies from Vertex Pharmaceutical (Nasdaq: VRTX).  SMC did not recommend …

News
cancer_cells

Second child cleared of leukaemia after Cellectis T-cell treatment

May 10, 2016
Manufacturing and Production, Research and Development cellecits, childhood, children, designer cells, leukaemia, rare, t cells, t-cells

A targeted T-cell oncology therapy has successfully treated a second baby with aggressive leukaemia who has remained in remission after …

News

China evaluating investigations into pharma firms to take on drug pricing issue

May 9, 2016
Business Services, Research and Development, Sales and Marketing China, France, G7, regulation

Lawmakers globally have acknowledged the concerns over unbridled drug costs as regulators stress the need for a more open debate …

News
abpi_reception_right

UK pharma would benefit by remaining in EU, says ABPI

May 9, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Andrew Witty, EU, brexit, letter, observer, pascal soriot, remain, stay

With the EU vote approaching, the Association of the British Pharmaceutical Industry (ABPI) has brought together 93 signatories, including the …

News
shutterstock_67313209

Focus: Governments evaluate policies, reforms as drug pricing debate rages on

May 9, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

By Anjali Shukla Lawmakers in France are set to urge the leaders of G7 countries to put in place guidelines …

Feature
hold_heart

Chiesi set to acquire Medicine Co cardiovascular assets, say reports

May 9, 2016
Sales and Marketing Chiesi, assets, cardiovascular, medicine co

Italian pharmaceutical company Chiesi are set to expand their global footprint as it nears an agreement to acquire Medicines Co’s …

News
stocks3

Endo shares plunge almost 40% as company cuts FY outlook

May 9, 2016
Sales and Marketing Endo International, earnings, outlook, revenue

Shares in Endo International (Nasdaq: ENDP) plunged to close down nearly 40% after the company cut its full-year earnings forecast …

News
needles

BTG acquires promising oncology pipeline in Galil Medical takeover

May 9, 2016
Manufacturing and Production, Research and Development, Sales and Marketing $84 million, BTG, cryoablation, galil medical, oncology, takeover

BTG (LSE: BTG) has announced that is has agreed to acquire Galil Medical, a leading provider of cryoablation products for …

News
allergan

Phase III trial meets primary endpoint for Allergan’s fibroid treatment

May 9, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Allergan, fibroid, phase 3, phase III, ulipristal, ulipristal acetate, uterine fibroid

Allergan (NYSE: AGN), in collaboration with Gedeon Richter, has announced positive results from a pivotal Phase III trial evaluating the …

News
stocks1

Weekly Movers: Bind Therapeutics, Sarepta, Idexx…

May 9, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pfizer (NYSE: PFE) and Amgen (Nasdaq: AMGN) are rumoured to be considering a bid for Medivation just as French drug …

Feature
stocks2

Clovis cuts staff by 35% after FDA knock back on lung cancer drug

May 6, 2016
Manufacturing and Production, Research and Development, Sales and Marketing FDA, Q1 results, clovis, failure, job cuts, job losses, rociletinib, workforce

Clovis Oncology (NASDAQ: CLVS) is set to cut up to 35% of its workforce following the US Food and Drug …

News

NICE recommends Sanofi, Amgen cholesterol drugs

May 6, 2016
Medical Communications, Sales and Marketing Amgen, Draft Guidance, NHS, NICE, Repatha, Sanofi, cardiovascular disease, cholesterol, final draft guidance, high cholesterol, praluent, recommendation, treatment

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending two new drugs for the …

News
fda_logo-web

KemPharm’s pain drug fails to get FDA committee backing for abuse-deterrent capabilities; shares plunge

May 6, 2016
Medical Communications, Sales and Marketing

Shares in KemPharm (Nasdaq: KMPH) more than halved in pre-market trading after a US Food and Drug Administration advisory panel …

News
tug-of-war

Focus: Medivation tug-of-war rumbles on

May 6, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, AstraZeneca, Medivation, Pfizer, Sanofi, billion dollar, competition, oncology, pipeline, promising, takeover, tug of war

Medivation (NASDAQ: MDVN) has been making all the headlines as a list of suitors’ line up, all vying to secure …

Feature
merck

Merck & Co Q1 sales hurt by generics, currency impact

May 6, 2016
Medical Communications, Sales and Marketing Financial, Merck & Co, Q1, Revenye, earnings, results, sales

US pharma major Merck & Co (NYSE: MRK) posted a drop in first-quarter sales impacted the launch of generic competition …

News
papa

Valeant announces new patient access and pricing committee; vows to correct past “mistakes”

May 6, 2016
Medical Communications, Sales and Marketing Valeant, joseph papa, new committee, patient access, price gouging, pricing

Valeant (NYSE: VRX) has announced the establishment of a new patient access and pricing committee that will be responsible for …

News
pfizerbrussels

Pfizer teams up with Wave Life Sciences for metabolic disease research

May 6, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, metabolic disease, nucelic acid therapies, partnership, wave life sciences

Pfizer (NYSE: PFE) has entered into a research, license and option agreement with Wave Life Sciences (NASDAQ: WVE) for the …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026